These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 23305549

  • 1. Effect of septal ablation on regional diastolic dysfunction and diastolic asynchrony in patients with hypertrophic obstructive cardiomyopathy: a follow-up study using speckle tracking echocardiography.
    Chen S, Duan F, Yuan J, Qiao S, Lv X, Hu F, Yang W, Zhang J, Yang Y.
    Echocardiography; 2013 May; 30(5):564-71. PubMed ID: 23305549
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of left ventricular diastolic function by global strain rate imaging in patients with obstructive hypertrophic cardiomyopathy: a simultaneous speckle tracking echocardiography and cardiac catheterization study.
    Chen S, Yuan J, Qiao S, Duan F, Zhang J, Wang H.
    Echocardiography; 2014 May; 31(5):615-22. PubMed ID: 24219240
    [Abstract] [Full Text] [Related]

  • 3. Ameliorating the severity of sleep-disordered breathing concomitant with heart failure status after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy.
    Akita K, Maekawa Y, Kohno T, Tsuruta H, Murata M, Fukuda K.
    Heart Vessels; 2017 Nov; 32(11):1320-1326. PubMed ID: 28555387
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy; The Chinese experience in 119 patients from a single center.
    Li ZQ, Cheng TO, Zhang WW, Qiao SB, Zhao LY, Jin YZ, Guan RM, Liu L.
    Int J Cardiol; 2004 Feb; 93(2-3):197-202. PubMed ID: 14975547
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of left ventricular myocardial perfusion and function using gated SPECT in patients with hypertrophic obstruction cardiomyopathy following percutaneous transluminal septal myocardial ablation.
    Zhang L, Liu R, Qiao SB, Sun XX, He ZX, Tian YQ.
    Nucl Med Commun; 2014 Jul; 35(7):762-6. PubMed ID: 24681766
    [Abstract] [Full Text] [Related]

  • 13. Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
    Veselka J, Honek T.
    Int J Cardiol; 2003 Mar; 88(1):27-32. PubMed ID: 12659981
    [Abstract] [Full Text] [Related]

  • 14. [Percutaneous transluminal septal myocardial ablation: early results and long-term follow-up].
    Tekieli Ł, Pieniazek P, Podolec P, Tomkiewicz-Pajak L, Płazak W, Musiałek P, Leśniak-Sobelga A, Przewłocki T, Biernacka B, Zmudka K, Tracz W.
    Przegl Lek; 2006 Mar; 63(8):628-32. PubMed ID: 17441371
    [Abstract] [Full Text] [Related]

  • 15. An assessment of left atrial function in patients with hypertrophic obstructive cardiomyopathy before and 1 year after septal ablation by two-dimensional speckle tracking echocardiography.
    Fang H, Tang H, Li P, Xiong L, Hu G, Li L, Yu Y, Zhao B.
    Echocardiography; 2017 Mar; 34(3):407-414. PubMed ID: 28130861
    [Abstract] [Full Text] [Related]

  • 16. Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up.
    Veselka J, Procházková S, Bolomová-Homolová I, Duchonová R, Tesar D.
    Echocardiography; 2005 Feb; 22(2):105-9. PubMed ID: 15693775
    [Abstract] [Full Text] [Related]

  • 17. Magnetic resonance imaging of microvascular obstruction in hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
    Amano Y, Kitamura M, Yamada F, Aita K, Takayama M, Tachi M, Kumita S.
    Acta Radiol; 2015 Nov; 56(11):1323-8. PubMed ID: 25414371
    [Abstract] [Full Text] [Related]

  • 18. Role of left ventricular regional diastolic abnormalities for global diastolic dysfunction in patients with hypertrophic cardiomyopathy.
    Goto K, Mikami T, Onozuka H, Kaga S, Inoue M, Komatsu H, Komuro K, Yamada S, Tsutsui H, Kitabatake A.
    J Am Soc Echocardiogr; 2006 Jul; 19(7):857-64. PubMed ID: 16824994
    [Abstract] [Full Text] [Related]

  • 19. Myocardial mechanical remodeling after septal myectomy for severe obstructive hypertrophic cardiomyopathy.
    Moravsky G, Bruchal-Garbicz B, Jamorski M, Ralph-Edwards A, Gruner C, Williams L, Woo A, Yang H, Laczay B, Rakowski H, Carasso S.
    J Am Soc Echocardiogr; 2013 Aug; 26(8):893-900. PubMed ID: 23800507
    [Abstract] [Full Text] [Related]

  • 20. Hypertrophic cardiomyopathy in pediatric patients: effect of verapamil on regional and global left ventricular diastolic function.
    Pacileo G, De Cristofaro M, Russo MG, Sarubbi B, Pisacane C, Calabrò R.
    Can J Cardiol; 2000 Feb; 16(2):146-52. PubMed ID: 10694584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.